Actively Recruiting
Risk Evaluation and Management in Heart Failure
Led by Ruijin Hospital · Updated on 2016-12-20
1000
Participants Needed
1
Research Sites
547 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is an prospective study conducted in a Chinese heart failure population. The study investigates the effects of cardiovascular disease risk factors such as lifestyle behaviors,biomarkers and intermediate diseases on heart failure prognosis.
CONDITIONS
Official Title
Risk Evaluation and Management in Heart Failure
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 18 years or older
- Inpatient with congestive heart failure (pulmonary edema, pulmonary congestion, or peripheral edema), cardiogenic shock, or insufficient high output cardiac function
- Diagnosed with impaired cardiac function by echocardiography
- Able to provide informed consent
You will not qualify if you...
- Expressed refusal to participate in the baseline investigation or follow-up visits
- Severe co-morbidity associated with a reduction in life expectancy of less than 12 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai Municipality, China, 200025
Actively Recruiting
Research Team
Z
Zhijun Wu, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here